|
CTMX Cytomx Therapeutics Inc 1501989 |
| Balance Sheet |
|
Current Assets
|
124,180,000 |
|
Assets
|
138,981,000 |
|
Current Liabilities
|
119,228,000 |
|
Liabilities
|
162,433,000 |
|
Equity
|
-23,452,000 |
|
Shares Out
|
78,118,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-66,323,000 |
|
Investing Cash Flow
|
84,565,000 |
| Market Analysis |
Market Cap
|
95,280,035 |
|
Price
|
0.84 |
|
BVPS
|
1.10 |
|
PB
|
0.76 |
|
EPS
|
0.14 |
|
PE
|
8.90 |
|
PS
|
0.71 |
|
FCF
|
18,242,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTMX documents filed with the SEC.
CTMX Filings
Clear
